Lemborexant (Dayvigo)
What is lemborexant?
Lemborexant is known as Dayvigo in the United States and Japan alike (デエビゴ on Japanese packaging). It belongs to the newer group of sleep medicines called orexin receptor antagonists (DORA): instead of sedating the whole brain, it blocks orexin, the brain's wake-promoting messenger, so the brain can shift from wakefulness to sleep.
How is it different from other sleeping pills?
- Dependence and tolerance are unlikely: in the trials, stopping it didn't cause withdrawal symptoms
- Helps you stay asleep through the night, not just fall asleep: its action is long, so it also covers waking in the early hours
- Blocks the wake signal rather than sedating the brain as a whole: a different way of working from benzodiazepine and Z-drug sleeping pills
- Works within the first week: no long build-up period
What is it used for in Japan?
Insomnia: both falling asleep and staying asleep.
What it targets: the whole night, including staying asleep; its longer action covers the early-morning hours.
How does it help?
By blocking the brain's wake signal, it helps you fall asleep and stay asleep through the night. It starts working within the first week, and it works best alongside good sleep habits.
What should I tell my doctor before starting?
A few situations rule it out entirely; your doctor will choose something else if any of these apply:
- A past allergic reaction to lemborexant
- Severe liver problems
And tell your doctor first if any of these apply; these usually just need adjustments or a closer eye:
- Narcolepsy or cataplexy
- Certain antifungals, antibiotics, or heart medicines (such as itraconazole, fluconazole, clarithromycin, erythromycin, or verapamil); your doctor will decide whether the combination is suitable, and if so, a lower dose is used
- Rifampicin or phenytoin, which can weaken its effect
- Mild or moderate liver problems, or severe kidney problems (a lower dose or a closer watch)
- A past brain injury, stroke, or other brain condition (the effect can be stronger)
- Moderate or severe lung or breathing problems, including sleep apnea
- Other sedating medicines, or regular alcohol use
- Pregnant, planning to be, or breastfeeding (see the section below)
How do I take it?
Once a night, right before bed, and only on nights you can give a full night to sleep.
- Take it immediately before lying down; avoid taking it with or just after a meal, which can delay the effect
- If you forget it, just skip that night. Never take a second dose in one night
- Avoid alcohol; the Japanese label asks for this because the two add to each other's effects on alertness
What side effects should I expect?
Most are mild. Not everyone gets them.
- Drowsiness or grogginess the next day (around 10%)
- Headache
- Tiredness
- Vivid or unusual dreams, or nightmares
If anything is bothering you, tell your doctor; there's often a way to adjust.
Finally, one thing that is uncommon (most people never experience it) but good to know:
- A brief feeling of being unable to move while falling asleep or waking (sleep paralysis), or dream-like impressions at the edge of sleep. It passes on its own and isn't dangerous, but it can be startling; tell us and the plan can be adjusted
Will I become dependent? How do I stop safely?
No; like the other newer sleep medicines, lemborexant is unlikely to cause dependence or tolerance. In the trials it kept working over months without the dose going up. The Japanese packaging still carries a standard notice that it may be habit-forming, so it is used at the prescribed dose and reviewed once sleep improves. It's best used for as long as you need it and no longer; the Japanese label asks for that review, and any change is made together.
Can I drive while taking it?
No. Don't drive after taking it, and be alert to leftover drowsiness the next morning. The Japanese label instructs that patients on lemborexant shouldn't drive or operate dangerous machinery, because the effect can carry into the next day. If morning sleepiness keeps happening, tell your doctor; the dose or the medicine can be changed.
What about pregnancy and breastfeeding?
Tell your doctor early; this is decided case by case. The Japanese label allows lemborexant in pregnancy only when the benefit is judged to outweigh the risk. With breastfeeding, it passes into milk in small amounts (under 2% of the mother's dose, by weight), and the label leaves the decision to be weighed individually. Don't start, stop, or continue on your own. Our guides to medication in pregnancy and medication while breastfeeding cover the wider picture.